Altre lingue GSK plc

Azioni

Mercato chiuso - London S.E. Altri mercati azionari 17:35:04 31/05/2024			Variaz. 5gg	Var. 1 gen.
1.766 ^GBX	+2,11%		-0,45%	+21,81%

01/06	GSK - IN MERITO ALLA SENTENZA DEL TRIBUNALE STATALE DELAWARE SUL CONTENZIOSO ZANTAC (RANITIDINA)...	RE
31/05	La FDA statunitense approva il vaccino RSV di Moderna, il suo secondo prodotto commercializzato	RE

GSK Regarding Ruling By Delaware State Court On Zantac Litigation Will Immediately Seek Appeal	01/06
US FDA approves Moderna's RSV vaccine, its second marketed product	31/05
GSK PLC : Goldman Sachs moins optimiste	30/05
GSK PLC : Goldman Sachs confirme sa recommandation neutre	30/05
Jefferies and UBS cut Anglo American	30/05
Dr Martens cuts payout as profit plummets	30/05
GSK : Upgraded to Neutral by Goldman Sachs	30/05
US nears deal to fund Moderna's bird flu vaccine trial, FT reports	30/05
European Equities Traded in the US as American Depositary Receipts Trend Sharply Lower in Wednesday Trading	29/05
Usa e Paesi europei considerano vaccinazione per lavoratori esposti a influenza aviaria	27/05
US, European nations consider vaccinating workers exposed to bird flu	27/05
British Stocks Extend Losing Streak Amid Retail Sales Slump	24/05
FTSE 100 falls; retail sales plunge in April	24/05
GSK celebrates Illinois jury verdict in Valadez case	24/05
GSK to Continue Vigorous Defense of Zantac Cancer Claims After Recent US Victory	24/05
UK retail sales fall amid wet April; Co-Op Bank deal	24/05
GSK, Boehringer Ingelheim Bag Win in Zantac Cancer Case US Trial	24/05
Sector Update: Health Care Stocks Retreat Late Afternoon	23/05
Sector Update: Health Care	23/05
GSK's Zantac Didn't Cause Woman's Cancer, Chicago Jury Verdict Says	23/05

Non ci sono risultati per questa ricerca

GSK plc torna di nuovo in pista

03 maggio 2024 alle 13:42

GSK PLC : Inizio incoraggiante per il 2024; aumentata la guidance